Centrilobular Emphysema Is Associated with Pectoralis Muscle Reduction in Current Smokers without Airflow Limitation
- PMID: 36689922
- PMCID: PMC10064397
- DOI: 10.1159/000529031
Centrilobular Emphysema Is Associated with Pectoralis Muscle Reduction in Current Smokers without Airflow Limitation
Abstract
Background: Physiological and prognostic associations of centrilobular emphysema (CLE) and paraseptal emphysema (PSE) in smokers with and without chronic obstructive pulmonary disease (COPD) have been increasingly recognized, but the associations with extrapulmonary abnormalities, such as muscle wasting, osteoporosis, and cardiovascular diseases, remain unestablished.
Objectives: The aim of the study was to investigate whether CLE was associated with extrapulmonary abnormalities independent of concomitant PSE in smokers without airflow limitation.
Methods: This retrospective study consecutively enrolled current smokers without airflow limitation who underwent lung cancer screening with computed tomography and spirometry. CLE and PSE were visually identified based on the Fleischner Society classification system. Cross-sectional areas of pectoralis muscles (PM) and adjacent subcutaneous adipose tissue (SAT), bone mineral density (BMD), and coronary artery calcification (CAC) were evaluated.
Results: Of 310 current smokers without airflow limitation, 83 (26.8%) had CLE. The PSE prevalence was higher (67.5% vs. 23.3%), and PM area, SAT area, and BMD were lower in smokers with CLE than in those without (PM area (mean), 34.5 versus 38.6 cm2; SAT area (mean), 29.3 versus 36.8 cm2; BMD (mean), 158.3 versus 178.4 Hounsfield unit), while CAC presence did not differ. In multivariable models, CLE was associated with lower PM area but not with SAT area or BMD, after adjusting for PSE presence, demographics, and forced expiratory volume in 1 s.
Conclusions: The observed association between CLE and lower PM area suggests that susceptibility to skeletal muscle loss could be high in smokers with CLE even without COPD.
Keywords: Chest computed tomography; Chronic obstructive pulmonary disease; Emphysema; Muscle wasting.
© 2023 The Author(s). Published by S. Karger AG, Basel.
Conflict of interest statement
Naoya Tanabe, Susumu Sato, Tsuyoshi Oguma, and Toyohiro Hirai were supported by a grant from FUJIFILM Co., Ltd. Susumu Sato received grants from Nippon Boehringer Ingelheim, Philips Respironics, Fukuda Denshi, Fukuda Lifetec Keiji, and ResMed outside of the submitted work. None of these companies played a role in the design or analysis of the study or in the writing of the manuscript. The other authors have no conflicts of interest to declare.
Figures


Similar articles
-
The prevalence and physiological impacts of centrilobular and paraseptal emphysema on computed tomography in smokers with preserved ratio impaired spirometry.ERJ Open Res. 2022 Jun 27;8(2):00063-2022. doi: 10.1183/23120541.00063-2022. eCollection 2022 Apr. ERJ Open Res. 2022. PMID: 35769415 Free PMC article.
-
Prediction of airflow limitation in smokers using multiple CT imaging indices: airway wall thickness, quantitative emphysema, and visually identified centrilobular emphysema.Respir Med. 2025 Aug;244:108169. doi: 10.1016/j.rmed.2025.108169. Epub 2025 May 20. Respir Med. 2025. PMID: 40404064
-
CT-defined visual emphysema in smokers with normal spirometry: association with prolonged air leak and other respiratory complications after lobectomy for lung cancer.Eur Radiol. 2022 Jul;32(7):4395-4404. doi: 10.1007/s00330-022-08540-w. Epub 2022 Jan 29. Eur Radiol. 2022. PMID: 35094117
-
Morphological and cellular basis for airflow limitation in smokers.Eur Respir J. 1994 Aug;7(8):1505-15. doi: 10.1183/09031936.94.07081505. Eur Respir J. 1994. PMID: 7957838 Review.
-
Disease of the airways in chronic obstructive pulmonary disease.Eur Respir J Suppl. 2001 Dec;34:41s-49s. doi: 10.1183/09031936.01.00234601. Eur Respir J Suppl. 2001. PMID: 12392034 Review.
Cited by
-
Cigarette smoking and disproportionate changes of thoracic skeletal muscles in low-dose chest computed tomography.Sci Rep. 2023 Nov 17;13(1):20110. doi: 10.1038/s41598-023-46360-0. Sci Rep. 2023. PMID: 37978301 Free PMC article.
-
Unveiling the Knowledge Frontier: A Scientometric Analysis of COPD with Sarcopenia.Int J Chron Obstruct Pulmon Dis. 2024 Mar 12;19:731-748. doi: 10.2147/COPD.S448494. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 38495217 Free PMC article.
-
Erector Spinae Muscle to Epicardial Visceral Fat Ratio on Chest CT Predicts the Severity of Coronavirus Disease 2019.J Cachexia Sarcopenia Muscle. 2025 Feb;16(1):e13721. doi: 10.1002/jcsm.13721. J Cachexia Sarcopenia Muscle. 2025. PMID: 39868664 Free PMC article.
-
Association between blood eosinophil count and small airway eosinophils in smokers with and without COPD.ERJ Open Res. 2023 Oct 2;9(5):00235-2023. doi: 10.1183/23120541.00235-2023. eCollection 2023 Sep. ERJ Open Res. 2023. PMID: 37868149 Free PMC article.
-
Antigravity muscle density on computed tomography and health-related independence in normal weight patients with chronic obstructive pulmonary disease.Respir Res. 2025 Apr 13;26(1):143. doi: 10.1186/s12931-025-03211-y. Respir Res. 2025. PMID: 40223070 Free PMC article.
References
-
- Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010 a systematic analysis for the global burden of disease Study 2010. Lancet. 2012;380((9859)):2224–2260. - PMC - PubMed
-
- Schaap LA, Pluijm SMF, Deeg DJH, Visser M. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med. 2006 Jun;119((6)):526.e9–617.e9. - PubMed
-
- Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EFM. Systemic effects of smoking. Chest. 2007 May;131((5)):1557–1566. - PubMed
-
- Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017;389((10082)):1931–1940. - PubMed